Lipodystrophy and inflammation predict later grip strength in HIV-infected men: The MACS body composition substudy

AIDS Research and Human Retroviruses

Volumn 29, Issue 8, 2013, Pages 1138-1145

  Crawford, Keith W ^a,b   Li, Xiuhong ^a   Xu, Xiaoqiang ^a   Abraham, Alison G ^a   Dobs, Adrian S ^a   Margolick, Joseph B ^a   Palella, Frank J ^c   Kingsley, Lawrence A ^d   Witt, Mallory D ^e   Brown, Todd T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR I; TUMOR NECROSIS FACTOR ALPHA RECEPTOR II; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCOSE BLOOD LEVEL; GRIP STRENGTH; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; BIOLOGICAL MARKERS; BODY COMPOSITION; C-REACTIVE PROTEIN; HAND STRENGTH; HIV INFECTIONS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LIPODYSTROPHY; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880558621     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0020     Document Type: Article

References (54)

1. Harrison KM, Song R, and Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr 2010; 53(1):124-130.
2. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, Vaeth M, and Obel N. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007;146(2):87-95.
3. Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, Huebner RE, Janoff EN, Justice AC, Kuritzkes D, et al.. Aging and infectious diseases. Workshop on HIV infection and aging. What is known and future research directions. Clin Infect Dis 2008;47(4):542-553.
4. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009;17(4):118-123.
5. Desai S and Landay A. Early immune senescence in HIV disease. Curr HIV/AIDS Rep 2010;7(1):4-10.
6. Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, and Margolick JB. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007;62(11):1279- 1286.
7. Onen NF, Agbebi A, Shacham E, Stamm KE, Onen AR, and Overton ET. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect 2009;59(5):346-352.
8. Marin RV, Pedrosa MA, Moreira-Pfrimer LD, Matsudo SM, and Lazaretti-Castro M. Association between lean mass and handgrip strength with bone mineral density in physically active postmenopausal women. J Clin Densitom 2010;13(1). 96-101.
9. Cauley JA, Fullman RL, Stone KL, Zmuda JM, Bauer DC, Barrett-Connor E, Ensrud K, Lau EM, and Orwoll ES. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int 2005;16(12):1525-1537.
10. Knudtson MD, Klein BE, and Klein R. Biomarkers of aging and falling. The Beaver Dam eye study. Arch Gerontol Geriatr 2009;49(1):22-26.
11. Chan BK, Marshall LM, Winters KM, Faulkner KA, Schwartz AV, and Orwoll ES. Incident fall risk and physical activity and physical performance among older men. The Osteoporotic Fractures in Men Study. Am J Epidemiol 2007; 165(6):696-703.
12. Lan TY, Hou SM, Chen CY, ChangWC, Lin J, Lin CC, LiuWJ, Shih TF, and Tai TY. Risk factors for hip fracture in older adults. A case-control study in Taiwan. Osteoporos Int 2010; 21(5):773-784.
13. Gale CR, Martyn CN, Cooper C, and Sayer AA. Grip strength, body composition, and mortality. Int J Epidemiol 2007;36(1):228-235.
14. Hsu FC, Kritchevsky SB, Liu Y, Kanaya A, Newman AB, Perry SE, Visser M, Pahor M, Harris TB, and Nicklas BJ. Association between inflammatory components and physical function in the health, aging, and body composition study. A principal component analysis approach. J Gerontol A Biol Sci Med Sci 2009;64(5):581-589.
15. Brinkley TE, Leng X, Miller ME, Kitzman DW, Pahor M, Berry MJ, Marsh AP, Kritchevsky SB, and Nicklas BJ. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci 2009;64(4):455-461.
16. Tiainen K, Hurme M, Hervonen A, Luukkaala T, and JylhaM. Inflammatory markers and physical performance among nonagenarians. J Gerontol A Biol SciMed Sci 2010;65(6):658-663.
17. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, et al.. Higher inflammatory marker levels in older persons. Associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009;64(11):1183-1189.
18. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, and Ferrucci L. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 2007; 102(3):919-925.
19. Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 2008;93(11 Suppl 1):S57-S63.
20. Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, and Gelato MC. Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr 2000;25(4):312-321.
21. Samaras K, Gan SK, Peake PW, Carr A, and Campbell LV. Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection. Obesity (Silver Spring) 2009;17(1):53-59.
22. Tien PC, Choi AI, Zolopa AR, Benson C, Tracy R, Scherzer R, Bacchetti P, Shlipak M, and Grunfeld C. Inflammation and mortality in HIV-infected adults. Analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 2010;55(3):316-322.
23. Guaraldi G, Stentarelli C, Zona S, Orlando G, Carli F, Ligabue G, Lattanzi A, Zaccherini G, Rossi R, Modena MG, et al.. Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis 2010;208(1). 222-227.
24. Brown TT, Xu X, John M, Singh J, Kingsley LA, Palella FJ, Witt MD, Margolick JB, and Dobs AS. Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls. A substudy of the Multicenter AIDS Cohort Study. AIDS Res Ther 2009;6:8.
25. Palella FJ Jr, Cole SR, Chmiel JS, Riddler SA, Visscher B, Dobs A, and Williams C. Anthropometrics and examinerreported body habitus abnormalities in the multicenter AIDS cohort study. Clin Infect Dis 2004;38(6):903-907.
26. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, and Pau AK. Guidelines for using antiretroviral agents among HIVinfected adults and adolescents. Ann Intern Med 2002; 137(5 Pt 2):381-433.
27. Brown T, Wang Z, Chu H, Palella FJ, Kingsley L, Witt MD, and Dobs AS. Longitudinal anthropometric changes in HIVinfected and HIV-uninfected men. J Acquir Immune Defic Syndr 2006;43(3):356-362.
28. Ridker PM and Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol 2008;79(8 Suppl):1544-1551.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. Homeostasis model assessment. Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-419.
30. Harrell FE Jr, Lee KL, and Mark DB. Multivariable prognostic models. Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15(4):361-387.
31. Margolick J, Li X, Detels R, et al.. Earlier occurrence of the frailty phenotype in HIV+ men than in HIV-men. The MACS. 18th Conference on Retroviruses and Opportunistic Infections, 2011, Boston. Abstract 794.
32. Terzian AS, Holman S, Nathwani N, Robison E, Weber K, Young M, Greenblatt RM, and Gange SJ, for the Women's Interagency HIV Study. Factors associated with preclinical disability and frailty among HIV-infected and HIVuninfected women in the era of cART. J Womens Health (Larchmt) 2009;18(12):1965-1974.
33. Bohannon RW, Bear-Lehman J, Desrosiers J, Massy-Westropp N, and Mathiowetz V. Average grip strength. A metaanalysis of data obtained with a Jamar dynamometer from individuals 75 years or more of age. J Geriatr Phys Ther 2007;30(1):28-30.
34. Massy-Westropp NM, Gill TK, Taylor AW, Bohannon RW, and Hill CL. Hand grip strength. Age and gender stratified normative data in a population-based study. BMC Res Notes 2011;14(4):127.
35. Peake J, Della Gatta P, and Cameron-Smith D. Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. Am J Physiol Regul Integr Comp Physiol 2010;298(6):R1485-1495.
36. Toth MJ, Ades PA, Tischler MD, Tracy RP, and LeWinter MM. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol 2006;109(2):179-187.
37. Brinkley TE, Leng X, Miller ME, Kitzman DW, Pahor M, Berry MJ, Marsh AP, Kritchevsky SB, and Nicklas BJ. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci 2009;64(4):455-461.
38. Stenholm S, Maggio M, Lauretani F, Bandinelli S, Ceda GP, Di Iorio A, Giallauria F, Guralnik JM, and Ferrucci L. Anabolic and catabolic biomarkers as predictors of muscle strength decline. The InCHIANTI study. Rejuvenation Res 2010;13(1):3-11.
39. Sternfeld B, Ngo L, Satariano WA, and Tager IB. Associations of body composition with physical performance and self-reported functional limitation in elderly men and women. Am J Epidemiol 2002;156(2):110-121.
40. Jensen GL. Inflammation. Roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr 2008;32(6):656-659.
41. Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med 2004;34(12):809-824.
42. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, Tylavsky FA, Rubin SM, and Harris TB. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006;61(1):72-77.
43. Maggio M, Cappola AR, Ceda GP, et al.. The hormonal pathway to frailty in older men. J Endocrinol Invest 2005;28. 15-19.
44. Stewart JW, Alekel DL, Ritland LM, Van Loan M, Gertz E, and Genschel U. Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause 2009;16(6):1093-1101.
45. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, and Lamberts SW. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab 2005;90(12):6403-6409.
46. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, and Tenover JL. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005;90(3):1502-1510.
47. Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, and Giorgino F. The GH/IGF1 axis and signaling pathways in the muscle and bone. Mechanisms underlying agerelated skeletal muscle wasting and osteoporosis. J Endocrinol 2010;205(3):201-210.
48. Koutkia P, Canavan B, Breu J, and Grinspoon S. Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy. J Clin Endocrinol Metab 2005;90(1):32-38.
49. Miller J, Carr A, Emery S, Law M, Mallal S, Baker D, Smith D, Kaldor J, and Cooper DA. HIV lipodystrophy. Prevalence, severity and correlates of risk in Australia. HIV Med 2003;4(3):293-301.
50. Lake JE and Adams JS. Vitamin D in HIV-infected patients. Curr HIV/AIDS Rep 2011;8(3):133-141.
51. Guaraldi G, Murri R, Orlando G, Squillace N, Stentarelli C, Zona S, Garlassi E, andMartínez E. Lipodystrophy and quality of life of HIV-infected persons. AIDS Rev 2008;10(3):152-161.
52. Chen CN, Chuang LM, and Wu YT. Clinical measures of physical fitness predict insulin resistance in people at risk for diabetes. Phys Ther 2008;88(11):1355-1364.
53. Abbatecola AM, Ferrucci L, Ceda G, Russo CR, Lauretani F, Bandinelli S, Barbieri M, Valenti G, and Paolisso G. Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci 2005;60(10):1278-1282.
54. Guimarães MM, de Oliveira AR Jr, Penido MG, Queiroz LC, Goulart EM, Greco DB, and Machado LJ. Ultrasonographic measurement of intra-abdominal fat thickness in HIVinfected patients treated or not with antiretroviral drugs and its correlation to lipid and glycemic profiles. Ann Nutr Metab 2007;51(1):35-41.